Test Price
2,800 AED✅ Home Collection Available
SYNE2 Gene Emery-Dreifuss Muscular Dystrophy Type 5 Genetic Test in UAE
Executive Summary & Core Metrics
99.9% Diagnostic Sensitivity – ISO 9001:2015 Certified | VIP Mobile Phlebotomy & Cold-Chain Home Collection | Same-Day Genetic Counselling | Direct Insurance Billing
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO-Accredited Processing using Next-Generation Sequencing.
- Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (Available daily from 8 AM to 11 PM).
- Clinical Guidance: Telephonic Post-Test Clinical Guidance and mandatory pre-test genetic counselling included.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Price: AED 2,800
Test Overview & Methodology
The SYNE2 Gene Emery-Dreifuss Muscular Dystrophy Type 5 Genetic Test uses Next-Generation Sequencing (NGS) to detect pathogenic variants in the SYNE2 gene, enabling a definitive molecular diagnosis of this rare neuromuscular disorder. In the UAE, this test is ordered by neurologists and clinical geneticists to confirm clinical suspicion, guide cardiac surveillance, and inform family planning.
| Feature | Our NGS Test | Legacy Sanger Sequencing |
|---|---|---|
| Precision | Full gene coverage (exons, splice sites) – detects novel & known variants | Limited to pre-selected hotspots; may miss rare mutations |
| Method | NGS (Illumina® platform) with bioinformatic verification | Sanger sequencing of individual amplicons |
| Speed | 3 to 4 Weeks | 6 to 8 Weeks (often fragmented) |
Physician Insight & Safety Protocols
“A positive SYNE2 genetic result provides definitive clarity, confirming Emery-Dreifuss type 5 and enabling targeted cardiac surveillance and precise familial risk assessment. I always emphasize correlating molecular findings with the clinical phenotype and a detailed pedigree analyzed by a qualified genetic counsellor.”
— Lina Osama Zaki Quteineh | Consultant Medical Genetics | DHA Registration ID: 9294403
Medication & Clinical Advisory
⚠️ Medication Advisory
Do not discontinue any prescribed cardiac or muscle-related medication without explicit instruction from your treating physician. This genetic test is a diagnostic aid and does not replace regular clinical monitoring or emergency intervention.
Patient Safety Exclusion Criteria & Red Flags
- Exclusion Criteria: Individuals under 18 years (mandatory legal guardian consent per Federal Decree-Law No. 4 of 2016 on Medical Liability); inability to provide a viable blood sample; active acute febrile illness (postpone collection until resolved).
- Emergency Red Flags: Sudden severe muscle weakness, difficulty breathing, palpitations or chest pain, unexplained falls—seek immediate medical attention.
Patient FAQ & Clinical Guidance
1. What does the SYNE2 gene test detect?
This NGS test identifies pathogenic variants in the SYNE2 gene causing Emery-Dreifuss muscular dystrophy type 5, enabling accurate diagnosis and family risk assessment. It reads the entire coding sequence to find mutations linked to muscle contractures, cardiac conduction defects, and gradual muscle wasting typical of EDMD5.
2. How is the sample collected and what is the turnaround time?
We collect a blood sample via painless venipuncture, with results available in 3 to 4 weeks. A certified phlebotomist visits your home (8 AM–11 PM) using temperature-controlled cold-chain transport to preserve DNA integrity until the lab processes it with NGS technology.
3. Is this test covered by UAE health insurance?
Most UAE insurers cover genetic testing with pre-authorization. Our team verifies coverage and handles direct billing via WhatsApp. We coordinate with Daman, AXA, NextCare, and others, providing the necessary ICD-10 codes and clinical justification for seamless approval.
UAE Regulatory & Data Privacy Adherence
DNA Labs UAE strictly complies with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Genetic data is handled with the highest level of confidentiality, encrypted storage, and restricted access. Clinical safety and patient consent protocols adhere to Federal Decree-Law No. 4 of 2016 on Medical Liability. Our laboratory is certified to ISO 9001:2015. Mandatory pre-test genetic counselling is conducted by our Consultant Medical Genetics specialist, Lina Osama Zaki Quteineh.
Clinical & Logistical Metadata
| Test Name | SYNE2 Gene Emery-Dreifuss Muscular Dystrophy Type 5 Genetic Test |
| Price (AED) | AED 2,800 |
| Turnaround Time | 3 to 4 Weeks |
| Sample Type / Matrix | Whole Blood (Peripheral) |
| Methodology Used | Next-Generation Sequencing (NGS) – Illumina® Platform |
| ICD-10-CM Code | G71.0 |
| LOINC Code | 88858-1 |
| DHA Facility License & Laboratory Address | DHA License: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians